ChengDa Pharmaceuticals Co. Ltd. Total Liabilities

Latest as of June 2026: CN¥251.32 Million CNY ≈ $36.78 Million USD

ChengDa Pharmaceuticals Co. Ltd. total liabilities. Based on the latest financial reports, ChengDa Pharmaceuticals Co. Ltd. (301201) has total liabilities worth CN¥251.32 Million CNY (≈ $36.78 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 301201 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of ChengDa Pharmaceuticals Co. Ltd. (2019–2025)

Total liabilities of ChengDa Pharmaceuticals Co. Ltd. from 2019 to 2025. This chart illustrates how ChengDa Pharmaceuticals Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data.

ChengDa Pharmaceuticals Co. Ltd. Competitors by Total Liabilities

The table below lists competitors of ChengDa Pharmaceuticals Co. Ltd. ranked by their total liabilities.

Company	Country	Total Liabilities
Darma Henwa Tbk JK:DEWA	Indonesia	Rp50.36 Billion
Faeth Therapeutics, Inc. NASDAQ:FTH	USA	$16.35 Million
Qingdao Topscomm Commun Inc SHG:603421	China	CN¥1.10 Billion
Suzhou Sunmun Technology Co Ltd SHE:300522	China	CN¥347.54 Million
Fineos Corporation Holdings Plc AU:FCL	Australia	AU$33.29 Million
Arvind Fashions Limited NSE:ARVINDFASN	India	Rs30.55 Billion
Sam-A Aluminiu KO:006110	Korea	₩309.99 Billion
WashTec AG XETRA:WSU	Germany	€234.07 Million

Liability Composition Analysis (2019–2025)

This chart breaks down ChengDa Pharmaceuticals Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 301201 asset base.

Liquidity & Leverage Metrics

ChengDa Pharmaceuticals Co. Ltd. Total Liabilities Ratios Explained

ChengDa Pharmaceuticals Co. Ltd. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	6.53	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.12	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ChengDa Pharmaceuticals Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ChengDa Pharmaceuticals Co. Ltd. (2019–2025)

The table below shows the annual total liabilities of ChengDa Pharmaceuticals Co. Ltd. from 2019 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥252.83 Million ≈ $37.00 Million	-13.05%
2024-12-31	CN¥290.77 Million ≈ $42.55 Million	+64.83%
2023-12-31	CN¥176.40 Million ≈ $25.81 Million	+66.71%
2022-12-31	CN¥105.81 Million ≈ $15.48 Million	-30.98%
2021-12-31	CN¥153.30 Million ≈ $22.43 Million	+103.59%
2020-12-31	CN¥75.30 Million ≈ $11.02 Million	-60.20%
2019-12-31	CN¥189.21 Million ≈ $27.69 Million	--

About ChengDa Pharmaceuticals Co. Ltd.

SHE:301201 China Drug Manufacturers - Specialty & Generic

Market Cap

$507.58 Million

CN¥3.47 Billion CNY

Market Cap Rank

#11770 Global

#3315 in China

Share Price

CN¥22.42

Change (1 day)

-3.40%

52-Week Range

CN¥22.42 - CN¥62.75

All Time High

CN¥86.94